Liposomal Skin Care Formulation for Transdermal Delivery

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current cosmetic and therapeutic skin care products are inadequate in effectively addressing skin aging and hair loss through topical application, as they fail to provide sufficient stimulation of collagen production and cell growth, leading to unmet needs for effective prevention and treatment of skin damage and wrinkles caused by environmental factors.

Innovation Solution

A transdermal skin care formulation comprising a blood product, such as plasma or serum, encapsulated in liposomes with a transdermal carrier, which facilitates systemic delivery of growth factors and other biologically active molecules to stimulate collagen production and improve skin texture and hair growth.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional cosmetic and therapeutic skin care products are used for topical application, then the formulation is simple and easy to manufacture, but they fail to effectively stimulate collagen production and cell growth, resulting in insufficient treatment of skin aging and hair loss

Engineering Contradiction:
Improveeffectiveness of collagen production stimulationVSAvoidformulation complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent uses liposomes as composite delivery vehicles that encapsulate blood serum components (growth factors, cytokines, extracellular matrix proteins) and combine them with transdermal penetration enhancers. This composite structure allows the formulation to effectively deliver biologically active molecules through the skin while maintaining stability and controlled release, thereby resolving the contradiction between treatment effectiveness and formulation complexity.

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The liposomal carrier acts as an intermediary that facilitates the transfer of blood serum components from the topical formulation to the deeper skin layers. The liposomes protect the growth factors and other biologically active molecules during transit through the stratum corneum, enabling effective delivery without requiring complex formulation methods.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If biological factors such as growth factors and peptide fragments are incorporated into anti-aging cosmetics, then the therapeutic effect is improved, but the formulation becomes more complex and difficult to stabilize

Engineering Contradiction:
Improvetherapeutic effectVSAvoidformulation stability
Core Design Contradiction:
ReliabilityVSStability of the object's composition

Solution Approach 1:

The patent employs liposomes with nested structures that encapsulate blood serum components containing growth factors, cytokines, and extracellular matrix proteins. This nested configuration protects the sensitive biologically active molecules from degradation while maintaining formulation stability, allowing them to remain effective throughout the product shelf life and upon skin application.

Inventive Principle:
Principle #7Nested doll (Nesting)

Solution Approach 2:

The liposomal formulation alters the physical and chemical parameters of the blood serum components by encapsulating them within the liposome structure. This changes their stability profile, protecting them from environmental factors such as oxidation and hydrolysis, thereby maintaining therapeutic effectiveness without requiring excessive formulation complexity.

Inventive Principle:
Principle #35Parameter changes

3Ease of operation

If topical products are used to treat skin aging and hair loss, then the application is non-invasive and easy to administer, but they fail to achieve sufficient penetration and systemic delivery of active components

Engineering Contradiction:
Improveease of administrationVSAvoidpenetration efficiency
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The patent incorporates transdermal penetration enhancers as intermediaries that facilitate the passage of liposomal-encapsulated blood serum components through the stratum corneum. These enhancers temporarily modify the skin barrier properties, allowing deeper penetration of the active ingredients while maintaining the non-invasive nature of topical application.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The formulation utilizes liposomes with specific size parameters and surface properties that optimize their penetration through the skin barrier. By controlling the liposome size, charge, and composition, the patent achieves enhanced transdermal delivery of blood serum components without requiring invasive administration methods, thus maintaining ease of use while improving penetration efficiency.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The formulation effectively reduces wrinkles and fine lines by up to 50% and improves skin texture and hair growth by stimulating collagen production and cell growth, offering an alternative to invasive treatments like cosmetic surgery or injectable fillers.

Implementation Method 1

a transdermal carrier; and a liposomal base; wherein at least a portion of the blood product and transdermal carrier is contained within liposomes of the liposomal base

Methodology Applied
Scientific EffectTransdermal delivery: Permeation

Implementation Method 2

at least a portion of the blood product and transdermal carrier is contained within liposomes of the liposomal base

Methodology Applied
Scientific EffectLiposomal encapsulation: Emulsion

Data Source

PatentUS11083687B2Skin care formulation
Publication Date: 2021.08.10 EMBRYOGENESIS PTY LTD

AI summary

There is provided a skin care formulation for transdermal administration of a component of a blood product, the formulation comprising a blood product, a transdermal carrier; and a liposomal base, wherein at least a portion of the blood product and transdermal carrier is contained within liposomes of the liposomal base.